Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples